相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
Man-Fung Yuen et al.
HEPATOLOGY (2020)
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conferences
Markus Cornberg et al.
JOURNAL OF HEPATOLOGY (2020)
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
Darren Wong et al.
LIVER INTERNATIONAL (2018)
Hepatitis B Cure: From Discovery to Regulatory Approval
Anna S. Lok et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg
Christine I. Wooddell et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels
Yuk-Fai Lam et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides
Elizabeth J. Ackermann et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides
Gaetan Billioud et al.
JOURNAL OF HEPATOLOGY (2016)
Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers
Stanley T. Crooke et al.
MOLECULAR THERAPY (2016)
Immune Response in Hepatitis B Virus Infection
Anthony Tan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Gi-Ae Kim et al.
GUT (2014)
Changes in Mipomersen Dosing Regimen Provide Similar Exposure With Improved Tolerability in Randomized Placebo-Controlled Study of Healthy Volunteers
JoAnn D. Flaim et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Mechanistic Understanding for the Greater Sensitivity of Monkeys to Antisense Oligonucleotide-Mediated Complement Activation Compared with Humans
Lijiang Shen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
Mark J. Graham et al.
CIRCULATION RESEARCH (2013)
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Danny Ka-Ho Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Patterns of hepatitis B surface antigen decline and HBV DNA suppression in Asian treatment-experienced chronic hepatitis B patients after three years of tenofovir treatment
Wai-Kay Seto et al.
JOURNAL OF HEPATOLOGY (2013)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
GUT (2012)
HBsAg seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma
Man-Fung Yuen et al.
GASTROENTEROLOGY (2008)
World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants
ML Funk et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism
JP Sheehan et al.
BIOCHEMISTRY (2001)
分享论文
